Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Bergonié
Emory University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Emory University
Children's Hospital Los Angeles
Dana-Farber Cancer Institute
BTG International Inc.
MacroGenics
Emory University
Celgene
Emory University
Nationwide Children's Hospital
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
University of Louisville
SillaJen, Inc.
City of Hope Medical Center
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
Children's National Research Institute
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)